| Financial Year |
March 31 2023 |
| Monetary Funds |
8,780,539,778.30 |
| Held-for-trading Financial Assets |
550,000,000.00 |
| Notes Receivable |
11,222,635.50 |
| Accounts Receivable |
5,883,528,217.91 |
| Advances to Suppliers |
368,188,717.65 |
| Other Receivables |
1,852,463,158.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,857,825,922.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
502,095,328.63 |
| Other Current Assets |
1,856,325,097.26 |
| Total Current Assets |
42,283,935,825.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
464,105,447.46 |
| Long-term Equity Investment |
1,845,682,599.47 |
| Investment Properties |
8,819,220.14 |
| Fixed Assetes |
2,136,044,350.00 |
| Under-construction Projects |
751,728,746.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,527,816.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
109,501,258.87 |
| Deferred Income Tax Assets |
152,314,065.85 |
| Other Non-Current Assets |
6,751,128,976.00 |
| Sub-Total of Non-Current Assets |
13,487,347,988.07 |
| Total Assets |
55,771,283,813.81 |
| Short-Term Loans |
4,971,508,088.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,027,964,131.69 |
| Accounts Payable |
20,282,916,590.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
116,617,899.94 |
| Taxes Payable |
510,309,756.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,684,125,186.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,206,352,603.16 |
| Other Current Liabilities |
2,317,675,887.56 |
| Sub-Total of Current Liabilities |
35,709,878,946.40 |
| Long-term Loans |
5,791,879,633.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,486,979.71 |
| Deferred Income Tax Liabilities |
104,850,797.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,014,455,085.07 |
| Total Liabilities |
41,724,334,031.47 |
| Paid-In Capital(Or Share Stock) |
1,856,527,072.00 |
| Capital Surplus |
5,100,829,135.94 |
| Surplus Reserve |
429,541,573.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,967,551,632.98 |
| Minority Stockholder's Interest |
693,074,810.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,353,874,971.81 |
| Owner's Equity（Stockholder's Equity） |
14,046,949,782.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
55,771,283,813.81 |
